Subscribe

Edgar Adams, ScD, Robin Carter, Heather Raschtschenia

Articles by Edgar Adams, ScD, Robin Carter, Heather Raschtschenia

Economic Considerations For REMS

ByEdgar Adams, ScD, Robin Carter, Heather Raschtschenia,Tom Noto, Covance Periapproval Services

June 13th 2009

Drug sponsors have options in both how the new FDA risk programs are structured and how to execute them

Latest Updated Articles

Economic Considerations For REMS
Published: June 13th 2009 | Updated:

Trending on Pharmaceutical Commerce

Lilly Announces Partnership with Walmart Pharmacy Launching First Retail Pick-Up Option Offering Direct-To-Consumer Priced Zepbound

Eli Lilly Planning $1.2 Billion Investment in Puerto Rico Manufacturing Site

Finding the Human Touch in a Wired World

© 2025 MJH Life Sciences^®

All rights reserved.